Home › Non-Small Cell Lung Cancer › Tennessee › Chattanooga

Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Chattanooga, TN

Isang pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Chattanooga. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Nagre-recruitPhase 3

Tennessee Oncology, PLLC - Chattanooga Downtown ( Site 0315), Chattanooga

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06623422

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

Nagre-recruitPhase 3

Tennessee Oncology - Chattanooga - Downtown, Chattanooga
Tennessee Oncology - Chattanooga - GHCR Site I, Chattanooga
Tennessee Oncology - Chattanooga - Memorial Plaza, Chattanooga

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06472245

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Nagre-recruitPhase 3

Tennessee Oncology, PLLC - Chattanooga Downtown, Chattanooga
Tennessee Oncology, PLLC - Chattanooga Med Park II, Chattanooga
Tennessee Oncology, PLLC - Chattanooga Memorial, Chattanooga
at 1 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07144280

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Nagre-recruitPhase 3

Tennessee Oncology, PLLC - Chattanooga Downtown, Chattanooga
Tennessee Oncology, PLLC - Chattanooga - Medical Park II, Chattanooga

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07222566

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Nagre-recruitPhase 2

Tennessee Oncology - Chattanooga, Chattanooga

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06667076

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Nagre-recruitPhase 3

Tennessee Oncology Chattanooga, Chattanooga

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06890598

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Nagre-recruitPhase 2

Research Site, Chattanooga

Edad 18 hanggang 95 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05061550

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Nagre-recruitPhase 3

Research Site, Chattanooga

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06692738

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Nagre-recruitPhase 3

Tennessee Oncology Chattanooga, Chattanooga

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06119581

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Nagre-recruitPhase 1/2

Tennessee Oncology, Chattanooga

Edad 18 pataas · Lahat ng kasarian · Na-update May 15, 2026 · NCT05379985

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Nagre-recruitPhase 3

Research Site, Chattanooga

Edad 18 hanggang 130 · Lahat ng kasarian · Na-update May 14, 2026 · NCT06417814

Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod

Iba pang pag-aaral sa Chattanooga

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.